UNITED THERAPEUTICS CORP
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: UNITED THERAPEUTICS CORP, 10-Q, 2000-08-14
Next: SOFTWALL EQUIPMENT CORP, NT 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED  FINANCIAL STATEMENTS AS OF AND FOR THE THREE MONTHS ENDED JUNE 30,
2000 AND IS  QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH UNAUDITED FINANCIAL
STATEMENTS  CONTAINED IN THE FORM 10-Q
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      95,038,647
<SECURITIES>                                14,034,984
<RECEIVABLES>                                  451,832
<ALLOWANCES>                                         0
<INVENTORY>                                    783,447
<CURRENT-ASSETS>                           111,597,602
<PP&E>                                       4,268,999
<DEPRECIATION>                               (351,721)
<TOTAL-ASSETS>                             123,372,565
<CURRENT-LIABILITIES>                        6,781,363
<BONDS>                                      1,766,605
                                0
                                          0
<COMMON>                                       188,653
<OTHER-SE>                                 114,622,123
<TOTAL-LIABILITY-AND-EQUITY>               123,372,565
<SALES>                                        496,303
<TOTAL-REVENUES>                               548,303
<CGS>                                          433,587
<TOTAL-COSTS>                               31,065,886
<OTHER-EXPENSES>                           (1,736,931)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              27,664
<INCOME-PRETAX>                           (28,810,316)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (28,810,316)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (28,810,316)
<EPS-BASIC>                                     (1.55)
<EPS-DILUTED>                                   (1.55)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission